Middleton’s football coach faces diabetes and amputation, but with the strength of his community, he's hoping to bring ...

First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...

With the Food and Drug Administration now allowing the over-the-counter purchase of continuous glucose monitors (CGMs)—small ...

Employers and benefits advisors could use a new database to find places where kidney care or diabetes care costs a lot more ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

Less than 5% of hospitalized adults with type 2 diabetes received an SGLT2 inhibitor or GLP-1 before being discharged, ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.

The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

Background Aortic stenosis is a degenerative condition with high mortality in its severe stages and no preventive treatment.